Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Long-Term Deferred Tax (2021 - 2025)

Historic Long-Term Deferred Tax for Neuroone Medical Technologies (NMTC) over the last 5 years, with Q3 2025 value amounting to $20.6 million.

  • Neuroone Medical Technologies' Long-Term Deferred Tax rose 731.54% to $20.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.6 million, marking a year-over-year increase of 731.54%. This contributed to the annual value of $20.6 million for FY2025, which is 731.54% up from last year.
  • Neuroone Medical Technologies' Long-Term Deferred Tax amounted to $20.6 million in Q3 2025, which was up 731.54% from $19.2 million recorded in Q3 2024.
  • In the past 5 years, Neuroone Medical Technologies' Long-Term Deferred Tax registered a high of $20.6 million during Q3 2025, and its lowest value of $8.9 million during Q3 2021.
  • Its 5-year average for Long-Term Deferred Tax is $15.3 million, with a median of $15.6 million in 2023.
  • In the last 5 years, Neuroone Medical Technologies' Long-Term Deferred Tax soared by 3590.28% in 2022 and then surged by 731.54% in 2025.
  • Over the past 5 years, Neuroone Medical Technologies' Long-Term Deferred Tax (Quarter) stood at $8.9 million in 2021, then skyrocketed by 35.9% to $12.1 million in 2022, then rose by 29.65% to $15.6 million in 2023, then rose by 22.59% to $19.2 million in 2024, then increased by 7.32% to $20.6 million in 2025.
  • Its last three reported values are $20.6 million in Q3 2025, $19.2 million for Q3 2024, and $15.6 million during Q3 2023.